http://articles.mercola.com/sites/articles/archive/2008/01/02/fda-approves.aspxFor the first time, the US Food and Drug Administration (FDA) has approved a genetically engineered protein for the treatment of moderate to severe rheumatoid arthritis. The drug, called etanercept (trade-name Enbrel), binds to tumor necrosis factor enCommunityServer 2008.5 SP1 (Build: 31106.3070)